Fetuin B Is a Secreted Hepatocyte Factor Linking Steatosis to Impaired Glucose Metabolism.

[1]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[2]  M. Febbraio,et al.  The Dual-Specificity Phosphatase 2 (DUSP2) Does Not Regulate Obesity-Associated Inflammation or Insulin Resistance in Mice , 2014, PloS one.

[3]  Z. Andrews,et al.  Hypothalamic Neurogenesis Is Not Required for the Improved Insulin Sensitivity Following Exercise Training , 2014, Diabetes.

[4]  P. Meikle,et al.  PLIN5 deletion remodels intracellular lipid composition and causes insulin resistance in muscle , 2014, Molecular metabolism.

[5]  F. Schick,et al.  Relationships of body composition and liver fat content with insulin resistance in obesity‐matched adolescents and adults , 2014, Obesity.

[6]  R. Bergman,et al.  FGF19 action in the brain induces insulin-independent glucose lowering. , 2013, The Journal of clinical investigation.

[7]  R. Schekman,et al.  Unconventional Secretion, Unconventional Solutions , 2013, Science.

[8]  P. Meikle,et al.  Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding , 2013, Diabetologia.

[9]  N. Stefan,et al.  Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans , 2013, Nature Medicine.

[10]  N. Stefan,et al.  The role of hepatokines in metabolism , 2013, Nature Reviews Endocrinology.

[11]  P. Meikle,et al.  Ceramides Contained in LDL Are Elevated in Type 2 Diabetes and Promote Inflammation and Skeletal Muscle Insulin Resistance , 2013, Diabetes.

[12]  H. Ressom,et al.  iTRAQ-based quantitative protein expression profiling and MRM verification of markers in type 2 diabetes. , 2012, Journal of proteome research.

[13]  N. Danial,et al.  Polysome Profiling in Liver Identifies Dynamic Regulation of Endoplasmic Reticulum Translatome by Obesity and Fasting , 2012, PLoS genetics.

[14]  S. Mukhopadhyay,et al.  Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance , 2012, Nature Medicine.

[15]  Juan Antonio Vizcaíno,et al.  Improvements in the protein identifier cross-reference service , 2012, Nucleic Acids Res..

[16]  L. Ryner,et al.  Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents , 2012, Diabetes Care.

[17]  G. Shulman,et al.  Mechanisms for Insulin Resistance: Common Threads and Missing Links , 2012, Cell.

[18]  R. Bergman,et al.  Simultaneous measurement of insulin sensitivity, insulin secretion and the disposition index in conscious unhandled mice , 2012, Obesity.

[19]  Brian J. Bennett,et al.  Comparative Analysis of Proteome and Transcriptome Variation in Mouse , 2011, PLoS genetics.

[20]  E. Ravussin,et al.  Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children , 2011, Diabetologia.

[21]  J. Yun,et al.  Plasma proteome analysis in diet‐induced obesity‐prone and obesity‐resistant rats , 2010, Proteomics.

[22]  M. Honda,et al.  A liver-derived secretory protein, selenoprotein P, causes insulin resistance. , 2010, Cell metabolism.

[23]  Yun-ping Zhu,et al.  Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: Enoyl–coenzyme a hydratase down‐regulation exacerbates hepatic steatosis , 2010, Hepatology.

[24]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[25]  D. James,et al.  Pigment epithelium-derived factor contributes to insulin resistance in obesity. , 2009, Cell metabolism.

[26]  D. Ribnicky,et al.  Failure of dietary quercetin to alter the temporal progression of insulin resistance among tissues of C57BL/6J mice during the development of diet-induced obesity , 2009, Diabetologia.

[27]  R. Kesterson,et al.  Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. , 2008, Cell metabolism.

[28]  R. DeFronzo,et al.  Strong association between insulin resistance in liver and skeletal muscle in non‐diabetic subjects , 2008, Diabetic medicine : a journal of the British Diabetic Association.

[29]  Pan Du,et al.  lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..

[30]  Xiaomin Song,et al.  iTRAQ experimental design for plasma biomarker discovery. , 2008, Journal of proteome research.

[31]  B. S. Mohammed,et al.  Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. , 2008, Gastroenterology.

[32]  D. Greco,et al.  Gene expression in human NAFLD. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[33]  Deepak Kolippakkam,et al.  Comprehensive and quantitative proteome profiling of the mouse liver and plasma , 2008, Hepatology.

[34]  C. Bogardus,et al.  Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. , 2008, The American journal of clinical nutrition.

[35]  K. Strissel,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2007, Diabetes.

[36]  J. K. Nicholson,et al.  Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice , 2007, Diabetologia.

[37]  F. Schick,et al.  α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans , 2006 .

[38]  H. Koyama,et al.  Association of serum fetuin-A with insulin resistance in type 2 diabetic and nondiabetic subjects. , 2006, Diabetes care.

[39]  A. Baranova,et al.  A genomic and proteomic study of the spectrum of nonalcoholic fatty liver disease , 2005, Hepatology.

[40]  M. Hawkins,et al.  The regulation of glucose effectiveness: how glucose modulates its own production , 2005, Current opinion in clinical nutrition and metabolic care.

[41]  J. Gromada,et al.  FGF-21 as a novel metabolic regulator. , 2005, The Journal of clinical investigation.

[42]  T. Suda,et al.  Angiopoietin-related growth factor antagonizes obesity and insulin resistance , 2005, Nature Medicine.

[43]  K. Petersen,et al.  Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. , 2005, Diabetes.

[44]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[45]  Jean-Charles Sanchez,et al.  Effect of high‐fat diet on the expression of proteins in muscle, adipose tissues, and liver of C57BL/6 mice , 2004, Proteomics.

[46]  J. George,et al.  Non‐alcoholic steatohepatitis in the Asia–Pacific region: Future shock? , 2004, Journal of gastroenterology and hepatology.

[47]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[48]  W. Jahnen-Dechent,et al.  Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A. , 2003, The Biochemical journal.

[49]  G. Pacini,et al.  Insufficient islet compensation to insulin resistance vs. reduced glucose effectiveness in glucose-intolerant mice. , 2002, American journal of physiology. Endocrinology and metabolism.

[50]  G. Grunberger,et al.  Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. , 2002, Diabetes.

[51]  Y. Higaki,et al.  Effect of mild exercise training on glucose effectiveness in healthy men. , 2001, Diabetes care.

[52]  G. Brandi,et al.  Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy , 2000, Annals of Internal Medicine.

[53]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions , 1999, American Journal of Gastroenterology.

[54]  H. Shamoon,et al.  Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.

[55]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[56]  R N Bergman,et al.  Role of Glucose Effectiveness in the Determination of Glucose Tolerance , 1996, Diabetes Care.

[57]  E. Kraegen,et al.  Development of Muscle Insulin Resistance After Liver Insulin Resistance in High-Fat–Fed Rats , 1991, Diabetes.

[58]  Matt Cave,et al.  Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease. , 2011, The Journal of nutritional biochemistry.

[59]  M. Watt,et al.  Adipose triacylglycerol lipase is a major regulator of hepatic lipid metabolism but not insulin sensitivity in mice , 2010, Diabetologia.

[60]  S. Schinner,et al.  Adipocyte Death, Adipose Tissue Remodeling, and Obesity Complications , 2009 .